JOHN KACZMAR

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology CHARLESTON, SC NPI 1134448079

General Payments — all program years on this page

$16,218.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,078.63 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Education $1,399.001
Food and Beverage $916.446
Travel and Lodging $763.195

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $2,185.827
EMD Serono, Inc. $374.991
Ipsen Biopharmaceuticals, Inc $240.602
Coherus Biosciences Inc. $140.351
Stryker Corporation $136.871

By program year

Program yearAmountRecords
2018 $83.621
2019 $8,489.3117
2021 $49.161
2022 $2,040.912
2023 $2,477.123
2024 $3,078.6312

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091980303 Ipsen Biopharmaceuticals, Inc $125.25 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091980305 Ipsen Biopharmaceuticals, Inc $115.35 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114400687 Regeneron Pharmaceuticals, Inc. $1,399.00 11/01/2024 Education Undisputed 01/23/2026 View at CMS
1114400689 Regeneron Pharmaceuticals, Inc. $23.63 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114400691 Regeneron Pharmaceuticals, Inc. $253.34 11/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114400693 Regeneron Pharmaceuticals, Inc. $24.05 11/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114400695 Regeneron Pharmaceuticals, Inc. $20.93 11/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114400697 Regeneron Pharmaceuticals, Inc. $438.87 11/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114400699 Regeneron Pharmaceuticals, Inc. $26.00 11/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1119870859 Stryker Corporation $136.87 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120246205 EMD Serono, Inc. $374.99 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147277904 Coherus Biosciences Inc. $140.35 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.